Literature DB >> 15889528

Protective action of acupuncture and moxibustion on gastric mucosa in model rats with chronic atrophic gastritis.

Xiyan Gao1, Hong Rao, Yan Wang, Dan Meng, Yulong Wei.   

Abstract

OBJECTIVE: To probe the mechanism of acupuncture and moxibustion in atrophic gastritis so as to provide a basis for clinical treatment.
METHOD: Observe the effects of acupuncture and moxibustion at the points of Zusanli, Zhongwan and Tianshu on gastric mucosa in model rats with chronic atrophic gastritis.
RESULTS: Acupuncture and moxibustion can increase the contents of PGE2alpha, PGF2alpha and cAMP, and decrease the content of cGMP in the tissue of gastric mucosa.
CONCLUSION: Acupuncture and moxibustion shows cytoprotection on gastric mucosa, so it is an effective method for treating chronic atrophic gastritis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15889528

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  4 in total

Review 1.  Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.

Authors:  Lorne J Hofseth
Journal:  Cancer Lett       Date:  2008-04-25       Impact factor: 8.679

2.  MOXIBUSTION ALLEVIATES GASTRIC PRECANCEROUS LESIONS IN RATS BY PROMOTING CELL APOPTOSIS AND INHIBITING PROLIFERATION-RELATED ONCOGENES.

Authors:  Li Peng; Yu-Feng Xie; Chen-Guang Wang; Huan-Gan Wu; Mi Liu; Ya-Dong Wang; Fu-Qiang Ma; Xiao-Rong Chang; Zong-Bao Yang
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-01-13

3.  Evaluation of influence of acupuncture and electro-acupuncture for blood perfusion of stomach by laser Doppler blood perfusion imaging.

Authors:  Zhang Dong; Li Shun-Yue; Wang Shu-You; Ma Hui-Min
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-20       Impact factor: 2.629

4.  Acupuncture Decreases NF-κB p65, miR-155, and miR-21 and Increases miR-146a Expression in Chronic Atrophic Gastritis Rats.

Authors:  Jialing Zhang; Kangbai Huang; Guoxin Zhong; Yong Huang; Suhe Li; Shanshan Qu; Jiping Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-18       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.